CompanyGraph
Ansell Limited
ANN · ASX · Australia
Price data from its ANN listing on CXA
ansell.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.49B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.03: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.14%Below 5Y avg (2.70%)
Annual Rate
AUD 0.75Paid semi-annual
Payout Ratio
53.4%Sustainable
Last Ex-Dividend
Feb 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.91BAUD3.49B · vs all stocks (USD)
Trailing P/E
27.40xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.84BAUD2.02B · vs all stocks (USD)
Profit Margin
6.74%vs Medical Instruments & Supplies peers
Beta
0.5750xvs all stocks
52-Week Change
1.07%vs all stocks
Forward Annual Dividend Yield
2.14%vs all stocks
Market Capitalization
4.91BAUD3.49B · vs all stocks (USD)
Enterprise Value
8.04BAUD5.72B · vs all stocks (USD)
Trailing P/E
27.40xvs Medical Instruments & Supplies peers
Forward P/E
16.62xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.49xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.83xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.83xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
16.21xvs Medical Instruments & Supplies peers
Profit Margin
6.74%vs Medical Instruments & Supplies peers
Operating Margin
14.31%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.71%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.96%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.84BAUD2.02B · vs all stocks (USD)
Revenue per Share (TTM)
13.89AUDUpdated Aug 21, 2026Quarterly Revenue Growth
0.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.20BAUD852.16M · vs all stocks (USD)
EBITDA (TTM)
260.20MAUD185.06M · vs all stocks (USD)
Net Income (TTM)
191.42MAUD136.14M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
61.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
392.31MAUD279.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
161.82MAUD115.09M · vs all stocks (USD)
Forward Annual Dividend Rate
0.7536AUDUpdated Aug 21, 2026Forward Annual Dividend Yield
2.14%vs all stocks
Trailing Annual Dividend Rate
0.8047AUDUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.29%vs all stocks
5-Year Average Dividend Yield
2.70%vs all stocks
Payout Ratio
53.43%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
19.10MUSDFY2025 · Jun 30, 2025Revenue
2.00BUSDFY2025 · Jun 30, 2025Cost of Goods Sold
1.18BUSDFY2025 · Jun 30, 2025Gross Profit
825.00MUSDFY2025 · Jun 30, 2025Operating Income
109.10MUSDvs all stocks (USD)
Pre-tax Income
143.90MUSDFY2025 · Jun 30, 2025Income Tax Expense
40.30MUSDFY2025 · Jun 30, 2025Net Income
103.60MUSDFY2025 · Jun 30, 2025EBIT
185.40MUSDFY2025 · Jun 30, 2025EBITDA (Income Statement)
260.20MUSDFY2025 · Jun 30, 2025Selling, General & Administrative
641.10MUSDFY2025 · Jun 30, 2025Non-operating Interest Income
6.30MUSDFY2025 · Jun 30, 2025Non-operating Interest Expense
41.50MUSDFY2025 · Jun 30, 2025EPS (Basic)
0.6990USDFY2025 · Jun 30, 2025EPS (Diluted)
0.6950USDFY2025 · Jun 30, 2025Basic Shares Outstanding
145.30MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
145.30MSharesFY2025 · Jun 30, 2025Minority Interests (P&L)
-2.00MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
238.30MUSDFY2025 · Jun 30, 2025Income Tax Paid
45.40MUSDFY2025 · Jun 30, 2025Capital Expenditures
-68.00MUSDFY2025 · Jun 30, 2025Net Acquisitions
-635.10MUSDFY2025 · Jun 30, 2025Purchase of Investments
-200.00KUSDFY2025 · Jun 30, 2025Net Investing Cash Flow
-703.30MUSDFY2025 · Jun 30, 2025Long-term Debt Issuance
35.30MUSDFY2025 · Jun 30, 2025Long-term Debt Payments
-117.30MUSDFY2025 · Jun 30, 2025Common Stock Repurchase
-4.40MUSDFY2025 · Jun 30, 2025Common Dividends Paid
-63.70MUSDFY2025 · Jun 30, 2025Other Financing Charges
-20.10MUSDFY2025 · Jun 30, 2025Net Financing Cash Flow
-170.20MUSDFY2025 · Jun 30, 2025Shares Outstanding
145.21MSharesUpdated Aug 21, 2026Float Shares
142.04MSharesUpdated Aug 21, 2026% Held by Insiders
1.56%vs all stocks
% Held by Institutions
66.42%vs all stocks
Total Cash (MRQ)
354.42MAUD252.08M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.75AUDUpdated Aug 21, 2026Total Debt (MRQ)
1.18BAUD838.28M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4163xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.36xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
19.41AUDUpdated Aug 21, 2026Total Assets
3.32BUSDvs all stocks (USD)
Total Current Assets
1.11BUSDFY2025 · Jun 30, 2025Total Liabilities
1.34BUSDFY2025 · Jun 30, 2025Total Non-current Assets
2.21BUSDFY2025 · Jun 30, 2025Total Non-current Liabilities
817.70MUSDFY2025 · Jun 30, 2025Total Current Liabilities
522.00MUSDFY2025 · Jun 30, 2025Cash
88.50MUSDFY2025 · Jun 30, 2025Cash Equivalents
149.80MUSDFY2025 · Jun 30, 2025Cash & Cash Equivalents
238.30MUSDFY2025 · Jun 30, 2025Accounts Receivable
306.90MUSDFY2025 · Jun 30, 2025Inventory
584.70MUSDFY2025 · Jun 30, 2025Accounts Payable
250.90MUSDFY2025 · Jun 30, 2025Short-term Debt
81.00MUSDFY2025 · Jun 30, 2025Deferred Revenue
20.90MUSDFY2025 · Jun 30, 2025Long-term Debt
724.60MUSDFY2025 · Jun 30, 2025Other Non-current Liabilities
26.40MUSDFY2025 · Jun 30, 2025Common Stock (Book)
1.03BUSDFY2025 · Jun 30, 2025Retained Earnings
1.10BUSDFY2025 · Jun 30, 2025Total Shareholders' Equity
1.98BUSDvs all stocks (USD)
52-Week Low
25.05AUDUpdated Aug 21, 202652-Week High
37.54AUDUpdated Aug 21, 202652-Week Change
1.07%vs all stocks
Beta
0.5750xvs all stocks
50-Day MA
32.11AUDUpdated Aug 21, 2026200-Day MA
31.53AUDUpdated Aug 21, 2026Avg 10-Day Volume
348.11KSharesUpdated Aug 21, 2026Avg 30-Day Volume
348.19KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
1.30AUDUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.03: safe zoneNotable
Altman Z-Score: 3.03
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.49B, above the global median of $1.15BNotable
Market cap (USD): 3,493,907,487.481Global Median: 1,146,734,693.424
Revenue is $2.02B, above the global median of $520.53MNotable
Revenue (USD): 2,021,244,706.273Global Median: 520,528,949.311
Levered free cash flow is $115.09M, above the global median of $16.24MNotable
Levered free cash flow (USD): 115,091,387.247Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hangzhou Iron & Steel Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shenzhen FRD Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Qatar Fuel Company Q.P.S.C.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kemira Oyj
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Osi Systems Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Rongtai Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Oxygen Plant Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Kunshan Kinglai Hygienic Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Mloptic Corp.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Medicover AB
Tier 1ProductionThroughput-Bound ConversionRuleFlow